Stock comparison
Haemonetics
Waters
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HAE
Haemonetics
Market cap
$2.88B
Sector
Healthcare
WAT
Waters
Market cap
$22.23B
Sector
Healthcare
Overall winner
Haemonetics HAE
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HAE | WAT | Winner |
|---|---|---|---|
| Warren Buffett | 70B | 63C | HAE |
| Benjamin Graham | 85A | 62C | HAE |
| Philip Fisher | 60C | 60C | Tie |
| Peter Lynch | 54C | 21F | HAE |
| Joel Greenblatt | 31F | 48D | WAT |
| Charlie Munger | 54D | 65C | WAT |
| Terry Smith | 55D | 59C | WAT |
Side-by-side metrics
| Metric | HAE | WAT |
|---|---|---|
| Market cap | $2.88B | $22.23B |
| P/E (TTM) | 24.8x | 63.6x |
| EV/EBIT | 14.1x | 30.7x |
| ROIC (TTM) | 8.37% | 2.25% |
| Gross margin | 55.74% | 55.02% |
| Net margin | 7.29% | 11.91% |
| Revenue CAGR 5y | 7.65% | 3.24% |
| EPS CAGR 5y | 24.62% | -1.02% |
| Debt / Equity | 1.5x | 0.3x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HAE leads on
- EPS CAGR 5y24.62%vs -1.02%+104%
- ROIC (TTM)8.37%vs 2.25%+73%
- P/E (TTM)24.8xvs 63.6x+61%
- Revenue CAGR 5y7.65%vs 3.24%+58%
WAT leads on
- Market cap$22.23Bvs $2.88B+87%
- Debt / Equity0.3xvs 1.5x+78%
- Net margin11.91%vs 7.29%+39%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.